Kinnate Biopharma Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 13.08 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -0.38% | -.--% | +11.81% |
06-13 | Kinnate Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | Kinnate Biopharma Inc. Announces Board Resignations | CI |
1st Jan change | Capi. | |
---|---|---|
+11.81% | 125M | |
+23.13% | 52.73B | |
+37.49% | 39B | |
-8.73% | 38.52B | |
+28.09% | 30.38B | |
-12.26% | 26.39B | |
+10.57% | 26.08B | |
+45.05% | 14.15B | |
+32.23% | 12.6B | |
-6.56% | 11.51B |
- Stock Market
- Equities
- KNTE Stock
- News Kinnate Biopharma Inc.
- Kinnate Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024